| Schedule of Company’s Segment Information |
The Company’s reportable segment information was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | (in millions) | | 2026 | | | | | | | | | | | | | | | | | | | | Connected Technology Solutions | | Essential Dental Solutions | | Orthodontic and Implant Solutions | | Wellspect Healthcare | | Total | | | | | | | | | | | | | | | | | | | Net sales | | $ | 246 | | | $ | 350 | | | $ | 199 | | | $ | 85 | | | $ | 880 | | | | | | | | | | | | | | | | | | | Adjusted cost of products sold (a) | | 156 | | | 132 | | | 104 | | | 37 | | | | | | | Adjusted selling expenses (b) | | 53 | | | 69 | | | 54 | | | 14 | | | | | | | Adjusted general and administrative (“G&A”) expenses (b) | | 23 | | | 20 | | | 21 | | | 8 | | | | | | | Adjusted research and development (“R&D”) expenses (c) | | 20 | | | 8 | | | 12 | | | 3 | | | | | | | | | | | | | | | | | | | | | | Segment adjusted operating income | | $ | (6) | | | $ | 121 | | | $ | 8 | | | $ | 23 | | | $ | 146 | | | | | | | | | | | | | | | | | | | | Reconciling items (income) expense: | | | | | | | | | | | | | | Unallocated corporate costs (d) | | | | | | | | | | $ | 72 | | | | | | Interest expense, net | | | | | | | | | | 24 | | | | | | Other income | | | | | | | | | | (17) | | | | | | Goodwill and intangible asset impairments | | | | | | | | | | — | | | | | | Restructuring and other costs | | | | | | | | | | 67 | | | | | | Amortization of intangibles | | | | | | | | | | 42 | | | | | | Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations | | | | | | | | | | — | | | | | | Loss before income taxes | | | | | | | | | | $ | (42) | | | | |
| | | | (a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs. | (b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs. | (c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs. | (d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | (in millions) | | 2025 | | | | | | | | | | | | | | Connected Technology Solutions | | Essential Dental Solutions | | Orthodontic and Implant Solutions | | Wellspect Healthcare | | Total | | | | | | | | | | | | | Net sales | | $ | 235 | | | $ | 353 | | | $ | 217 | | | $ | 74 | | | $ | 879 | | | | | | | | | | | | | Adjusted cost of products sold (a) | | 135 | | | 124 | | | 93 | | | 27 | | | | Adjusted selling expenses (b) | | 57 | | | 71 | | | 54 | | | 13 | | | | Adjusted G&A expenses (b) | | 19 | | | 18 | | | 22 | | | 6 | | | | Adjusted R&D expenses (c) | | 17 | | | 5 | | | 11 | | | 2 | | | | | | | | | | | | | | | | Segment adjusted operating income | | $ | 7 | | | $ | 135 | | | $ | 37 | | | $ | 26 | | | $ | 205 | | | | | | | | | | | | | | Reconciling items (income) expense: | | | | | | | | | | | Unallocated corporate costs (d) | | | | | | | | | | $ | 87 | | | Interest expense, net | | | | | | | | | | 19 | | | | | | | | | | | | | | | | | | | | | | | | | Restructuring and other costs | | | | | | | | | | 9 | | | Amortization of intangibles | | | | | | | | | | 45 | | | Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations | | | | | | | | | | 1 | | | Income before income taxes | | | | | | | | | | $ | 44 | |
| | | | (a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs. | (b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs. | (c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs. | (d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment. |
Depreciation and Amortization | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | (in millions) | | 2026 | | 2025 | | | | | | | | | | | | | | | Connected Technology Solutions | | $ | 37 | | | $ | 43 | | | | | | | Essential Dental Solutions | | 8 | | 9 | | | | | | | Orthodontic and Implant Solutions | | 23 | | 19 | | | | | | | Wellspect Healthcare | | 5 | | 2 | | | | | | | All other (a) | | 6 | | 6 | | | | | | | Total | | $ | 79 | | | $ | 79 | | | | | |
(a) Includes unallocated corporate costs for depreciation and amortization. The cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | December 31, 2025 | | Provisions | | Amounts Applied | | Change in Estimates | | March 31, 2026 | | | | | | | | | | | | | Connected Technology Solutions | | $ | 1 | | | $ | 23 | | | $ | (2) | | | $ | — | | | $ | 22 | | | Essential Dental Solutions | | 4 | | | 17 | | | (3) | | | — | | | 18 | | | Orthodontic and Implant Solutions | | 3 | | | 21 | | | (4) | | | — | | | 20 | | | Wellspect Healthcare | | 2 | | | 1 | | | — | | | — | | | 3 | | | All Other | | 2 | | | 5 | | | (1) | | | — | | | 6 | | | Total | | $ | 12 | | | $ | 67 | | | $ | (10) | | | $ | — | | | $ | 69 | |
|